Close Menu
The Westside GazetteThe Westside Gazette
    Facebook X (Twitter) Instagram
    • About Us
    • Contact
    • Media Kit
    • Political Rate Sheet
    • Links
      • NNPA Links
      • Archives
    • SUBMIT YOUR VIDEO
    Facebook X (Twitter) Instagram
    The Westside GazetteThe Westside Gazette
    Advertise With Us
    • Home
    • News
      • National
      • Local
      • International
      • Business
      • Releases
    • Entertainment
      • Photo Gallery
      • Arts
    • Politics
    • OP-ED
      • Opinions
      • Editorials
      • Black History
    • Lifestyle
      • Health
      • HIV/AIDS Supplements
      • Advice
      • Religion
      • Obituaries
    • Sports
      • Local
      • National Sports
    • Podcast and Livestreams
      • Just A Lil Bit
      • Two Minute Warning Series
    The Westside GazetteThe Westside Gazette
    You are at:Home » 580,000 bottles of a Blood Pressure Drug  recalled over cancer risk FDA says
    Health

    580,000 bottles of a Blood Pressure Drug  recalled over cancer risk FDA says

    November 13, 20251 Min Read0 Views
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr Email Reddit
    Screenshot
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email
    Advertisement

    Moneywatch

    Submitted by CBS/AP

    (Source: cbsnews.com)

    The Federal Drug Administration said drugmakers have recalled more than 580,000 bottles of a blood pressure medication over concerns that it may include a cancer-causing chemical.

    New Jersey-based drugmaker Teva Pharmaceuticals USA and drug distributor Amerisource Health Services issued voluntary nationwide recalls earlier this month of over half a million bottles of various strengths of prazosine capsules, according to the FDA.

    The capsule drug, known as prazosin hydrochloride, comes in 1 mg, 2 mg and 5 mg doses. It helps relax blood vessels to facilitate blood flow and is sometimes prescribed for nightmares and other sleep disturbances caused by post-traumatic stress disorder.

    Teva Pharmaceuticals did not immediately respond to a request for comment.

    In its recall orders posted on its website, the FDA said it has classified the affected lots of the recalled drug as a Class II risk because some of the medication may have nitrosamine impurities that are considered potentially carcinogenic. The chemicals can form when a drug is manufactured or stored, according to the agency.

    In its recall orders posted on its website
    Share. Facebook Twitter Pinterest LinkedIn Reddit WhatsApp Telegram Email
    Carma Henry

    Carma Lynn Henry Westside Gazette Newspaper 545 N.W. 7th Terrace, Fort Lauderdale, Florida 33311 Office: (954) 525-1489 Fax: (954) 525-1861

    Related Posts

    NOVEMBER IS NATIONAL DIABETES AWARENESS MONTH

    November 13, 2025

    THE RELIGION CORNER: A Mother’s Legacy — Fighting Diabetes in Black America

    November 12, 2025

    COVID Nearly Took My Life, Then Came Cancer: How I Fought Back!

    November 12, 2025
    Advertisement

    View Our E-Editon

    Advertisement

    –>

    Advertisement
    advertisement

    Advertisement

    –>

    The Westside Gazette
    Facebook X (Twitter) Instagram Pinterest
    © 2025 The Westside Gazette - Site Designed by No Regret Media.

    Type above and press Enter to search. Press Esc to cancel.

    Go to mobile version